UC San Diego researchers have found a “genetic switch” triggering neurodegeneration in both a rare childhood dementia and Alzheimer’s disease, pointing to new drug targets in the waste-processing system within the brain’s immune cells.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
